Pharmaceutical Manufacturing - Integrated CMC Platforms for Scalable Pharmaceutical Manufacturing
View as a Web Page
News Medical
 
  Pharmaceutical Manufacturing Pharmaceutical Manufacturing logo  
  The latest pharmaceutical manufacturing news from News Medical  
 

Boost your pharmaceutical OSD productionBoost your pharmaceutical OSD production

Are you tired of poor results, mistakes and problems during production? L.B. Bohle can solve your production issues with its cutting-edge technology for weighing, dry and wet granulation, milling and sieving, blending, tablet coating and product handling in both batch and continuous manufacturing

Enhance OSD Processes
 
 
    Integrated CMC Platforms for Scalable Pharmaceutical ManufacturingIntegrated CMC Platforms for Scalable Pharmaceutical Manufacturing
 
Pharmaron delivers an integrated CMC platform supporting small molecule APIs and drug products from early development through commercial manufacturing. Scientists gain expertise in process development, materials science, analytics, and regulatory quality systems, backed by global facilities in China, the UK, and the US for scalable, compliant pharmaceutical manufacturing worldwide projects.
 
Download the full CMC platform eBook
 
 
   CHITOSE and FUJIFILM Biosciences form strategic alliance to drive global innovation and biopharmaceutical manufacturingCHITOSE and FUJIFILM Biosciences form strategic alliance to drive global innovation and biopharmaceutical manufacturing
 
Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development services, and FUJIFILM Biosciences Inc., a global leader in the innovation and manufacture of cell culture solutions for the life science market, today announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmaceutical production.
 
   New Molecular Reshuffle May Unlock Chemical ReactionsNew Molecular Reshuffle May Unlock Chemical Reactions
 
The study uncovers a key mechanism in the [1,2]-Wittig rearrangement, opening avenues for selective chemical reactions in pharmaceutical applications.
 
   Artificial intelligence unlocks new frontiers in RNA drug designArtificial intelligence unlocks new frontiers in RNA drug design
 
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026